HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival.
HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. — المؤلف: Yan, Han — Cancer letters 20191101
- المؤلف
- Yan, Han
- النشر
- Cancer letters 20191101
- الوصف
- 333-340 p.
- الموضوعات
- Biomarkers, Tumor؛ Carcinoma in Situ؛ Carcinoma, Pancreatic Ductal؛ Female؛ Humans؛ Immunoglobulins؛ Immunohistochemistry؛ Male